Ovid Therapeutics (OVID) Asset Utilization Ratio (2021 - 2026)
Ovid Therapeutics' (OVID) Asset Utilization Ratio came in at 0.01 for Q2 2026, down 91.7% from 0.08 a year earlier and down 81.7% from the prior quarter.
Powered by 
Analysis
Ovid Therapeutics (OVID) Asset Utilization Ratio (2021 - 2026) Analysis & Trends
For FY2025, Ovid Therapeutics' Asset Utilization Ratio stood at 0.06.
- In prior years, Ovid Therapeutics' Asset Utilization Ratio was 0.00 in FY2024 (+83.0%), 0.00 in FY2023 (-69.5%), 0.01 in FY2022 (-99.4%) and 1.54 in FY2021 (+857.3%).
- The Q2 2026 figure stands as the lowest quarterly Asset Utilization Ratio since Q1 2025.
- On a year-over-year basis, Asset Utilization Ratio increased in four of the last five quarters, with growth averaging 148.7%.
- The strongest year-over-year quarter for Asset Utilization Ratio in the past five years was Q1 2026, with growth of 499.9%; the weakest was Q2 2022, with a decline of 99.2%.
- According to Business Quant data, Asset Utilization Ratio for the three prior quarters was 0.04 (Q1 2026), 0.07 (Q4 2025) and 0.09 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 0.49 |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 0.47 |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 0.52 |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 0.44 |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 0.53 |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 0.40 |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 0.58 |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 0.31 |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 0.47 |
| 10 | Ovid Therapeutics | 460.04 Mn | 92.06 Mn | - | 0.01 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.01 |
| Mar 31, 2026 | 0.04 |
| Dec 31, 2025 | 0.07 |
| Sep 30, 2025 | 0.09 |
| Jun 30, 2025 | 0.08 |
| Mar 31, 2025 | 0.01 |
| Dec 31, 2024 | 0.01 |
| Sep 30, 2024 | 0.01 |
| Jun 30, 2024 | 0.00 |
| Mar 31, 2024 | 0.00 |
| Dec 31, 2023 | 0.00 |
| Sep 30, 2023 | 0.00 |
| Jun 30, 2023 | 0.00 |
| Mar 31, 2023 | 0.00 |
| Dec 31, 2022 | 0.01 |
| Sep 30, 2022 | 0.01 |
| Jun 30, 2022 | 0.01 |
| Mar 31, 2022 | 0.01 |
| Dec 31, 2021 | 1.04 |
| Sep 30, 2021 | 1.01 |
API Access
Ovid Therapeutics Asset Utilization Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=OVID&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "asset-utilization-ratio", "ticker": "OVID", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=OVID&period=max&api_key=YOUR_API_KEY");
const data = await res.json();